Skip to main content

Biopharma Startups

Updated November 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 915 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
915
Total Funding
$794.0M
Avg Funding
$31.8M
Global Reach
9
countries

Top Cities for Biopharma

Lille
Cambridge
Cork
Westlake Village
Vilnius
Houston

Recently Funded Companies

Export
Lille, France

4Moving Biotech is a biopharmaceutical company that develops osteoarthritis drugs for osteoarthritis patients.

$14.3M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom

Monument Therapeutics used digital biomarkers to develop innovative new drugs for neuropsychiatric disorders including schizophrenia

Feb 2026

Founder Contacts

41,000+ verified contacts

Cork, Ireland

ArrayPatch is a biotech company that specializes in clinical development services.

$2.2M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Westlake Village, United States

Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.

$130.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Vilnius, Lithuania

Pioneera Biosciences disrupts next-generation immune therapies through its immune orchestration platform

$5.3M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Houston, United States

Coya Therapeutics is a T Reg platform company addressing neurodegenerative, autoimmune, and metabolic diseases

$11.1M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

New York, United States

Epikast provides technology-enabled commercial and clinical services for the biopharmaceutical industry.

$2.2M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Houston, United States

Pranax is a biotechnology company that develops and commercializes regenerative medicine solutions centered on exosome technology.

$17.0M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Chicago, United States

Prenosis develops data-driven diagnostic tools and precision medicine solutions for acute care conditions.

$20.0M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Berkeley, United States

Innovative Genomics Institute uses genome editing to develop accessible solutions in human health, climate, and agriculture.

Jan 2026

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark

Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry.

$5.9M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Fort Lauderdale, United States

Kaida BioPharma develops therapies for treatment-resistant gynecological cancers, focusing on ovarian cancer and hormone-driven diseases.

$1.6M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Lyon, France

ErVimmune develops cancer vaccines and T cell therapies targeting cold tumors using AI-driven antigen discovery.

$19.9M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Richmond, United States

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.

$115.0M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Burlingame, United States

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.

$201.0M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Mendra uses AI to accelerate clinical development and commercialization of breakthrough medicines for diseases with high unmet need.

$82.0M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Sevilla, Spain

Universal Diagnostics is a biotechnology firm that develops minimally invasive, blood-based solutions for the early detection of cancer.

$34.9M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Asse, Belgium

Trince is advancing cell-based science and therapeutics by facilitating the delivery of molecules into cells, both in vitro and ex vivo.

$6.1M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Chester, United Kingdom

Canton Strategic Holdings drives institutional blockchain adoption via the Canton Network, digital assets, and market digitization.

$55.0M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Sunnyvale, United States

BrightInsight offers a global regulated digital health platform for biopharma and medtech.

$13.0M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

San Mateo, United States

PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.

$11.9M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Surrey, Canada

Eyam Health concentrates on the investigation and creation of vaccines for defending against infectious diseases.

$327K raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Caldera Therapeutics is a biotech company engaged in the development of bispecific antibody CLD-423 for inflammatory bowel disease (IBD).

$37.5M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Garden City, United States

Beyond Air is a biotechnology company that focuses on the development of drugs for the treatment of lung infections.

$5.0M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Axol Bioscience sells live human cell cultures and provides services such as genome editing to researchers.

$2.8M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Showing 201 to 225 of 915 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 915 biopharma companies tracked in the VCBacked database.

Average Funding
$31.8M
Total Funding Tracked
$794.0M
Countries Represented
9

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.Cambridge
3 companies$40.3M
2.Houston
2 companies$28.1M
3.Lille
1 companies$14.3M
4.Cork
1 companies$2.2M
5.Westlake Village
1 companies$130.0M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked